Proteon Therapeutics Initiates Patient Enrollment in Phase 1 Clinical Study of PRT-201 in Patients Suffering from Peripheral Artery Disease

Proteon Therapeutics announced that it has begun enrollment in its Phase 1 clinical trial to treat patients with peripheral artery disease.... [more]

View complete Press Release article